The Mumbai-based drug major reported a net profit of Rs 3,040 crore for the July-September quarter of the last fiscal. Its revenue from operations increased to Rs 14,405 crore in the September quarter against Rs 13,264 crore in the year-ago period, Sun Pharma said in a regulatory filing.
